Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
The Evolution of Money European Central Bank Addresses Technological Disruption in Financial Services TrumpBacked Candidate Unseats Incumbent GOP Senator in Louisiana Primary Policy Implications Understanding Japans Economic Landscape Through Cultural Nuances CSP Inc CSPI Q1 2026 Earnings Preview What to Expect Fuel Price Hike May Pressure Cement Companies Profit Margins Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond ICRA Flags Sharp Decline in IBC Recovery Rates to 22 in H2 FY26 How TIPS Bridges Could Help Optimize Social Security Benefits Grabs Anthony Tan Wins Top Honor at Singapore Business Awards Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Tensions Rise Freedom Holding Corp FRHC Q1 2026 Earnings Solid EPS Reported Amid Quiet Disclosure Shares Slip PBYI Q1 2026 Earnings EPS Surprise of 4721 as Narrowed Loss Beats Estimates Heritage Global Inc HGBL Q1 2026 Earnings EPS Misses Estimates as Company Reports Modest Profits INSM Q1 2026 Earnings EPS Beat Surprises Market Stock Slides 3 BRAG Q1 2026 Earnings EPS Surpasses Estimates Amid Prudent Cost Controls GeneDx Holdings Q1 2026 Earnings Significant EPS Miss Shares Decline SmartKem Inc SMTK Edges Higher MicroCap Stock Holds Above Key Support After Modest Gain Hercules Capital Inc HTGC Slides Slightly Amidst Consolidation Phase MGR Preferred Shares Edge Lower Testing Key Support Levels Amid Yield Environment Arrive AI Inc ARAI Rises 13 Nears Key Resistance at 067 HealthEquity HQY Gains 115 as Shares Test MidRange Resistance XPO Q1 2026 Earnings EPS Surges 14 Above Estimates Stock Eases TNMG Q4 2025 Earnings Massive EPS Miss and Stock Rally A Contradiction ICICI Bank IBN Q1 2026 Earnings Modest EPS Beat Supports Slight Stock Upswing KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline